Capstone Green Energy Holdings, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Capstone Green Energy Holdings, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $85.56M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $91.22M | Jun 27, 2025 |
| FY2019 | Mar 31, 2019 | $83.41M | Jun 11, 2019 |
| FY2019 | Mar 31, 2018 | $82.84M | Jun 11, 2019 |
| FY2016 | Mar 31, 2016 | $85.21M | Jun 9, 2016 |
| FY2016 | Mar 31, 2015 | $115.46M | Jun 9, 2016 |
| FY2016 | Mar 31, 2014 | $133.11M | Jun 9, 2016 |
| FY2015 | Mar 31, 2013 | $127.56M | Jun 15, 2015 |
| FY2014 | Mar 31, 2012 | $109.37M | Jun 12, 2014 |
| FY2012 | Mar 31, 2011 | $81.89M | Jun 13, 2013 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Mar 31, 2018 | $82.84M | Jun 7, 2018 |
| FY2018 | Mar 31, 2017 | $77.17M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | $85.21M | Jun 13, 2017 |
| FY2016 | Mar 31, 2015 | $115.46M | Jun 9, 2016 |
| FY2016 | Mar 31, 2014 | $133.11M | Jun 9, 2016 |
| FY2015 | Mar 31, 2013 | $127.56M | Jun 15, 2015 |
| FY2014 | Mar 31, 2012 | $109.37M | Jun 12, 2014 |
| FY2012 | Mar 31, 2011 | $81.89M | Jun 13, 2013 |
| FY2011 | Mar 31, 2010 | $61.55M | Jun 14, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $23.30M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $14.28M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $9.06M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $1.70M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $3.39M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $2.51M | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | ($185.0K) | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $2.08M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $3.14M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $609.0K | Jun 13, 2024 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($7.19M) | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $7.39M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | ($24.52M) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | ($6.34M) | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | ($3.65M) | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | ($4.20M) | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | ($7.30M) | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | ($5.29M) | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | ($5.56M) | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | ($4.22M) | Jun 13, 2024 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($5.57M) | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | ($20.35M) | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | ($18.46M) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | ($4.53M) | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | ($2.32M) | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | ($2.90M) | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | ($6.09M) | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | ($3.99M) | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | ($4.28M) | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | ($5.60M) | Jun 13, 2024 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.67M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $2.46M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $2.38M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $633.0K | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $603.0K | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $490.0K | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | $722.0K | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $767.0K | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $987.0K | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $883.0K | Jun 13, 2024 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $26.21M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $32.18M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $25.15M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $5.60M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $5.11M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $4.92M | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | $5.19M | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $5.29M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $6.44M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $5.32M | Jun 13, 2024 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $7.69M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | ($27.66M) | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | ($7.94M) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | ($8.42M) | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | ($2.98M) | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | ($3.57M) | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | ($27.50M) | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | ($22.99M) | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | ($19.36M) | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | ($10.14M) | Jun 13, 2024 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $879.0K | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $4.67M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $8.22M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $4.00M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $2.56M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $1.89M | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | $9.92M | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $5.75M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $2.62M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $1.20M | Jun 13, 2024 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $74.86M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $84.21M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $108.03M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $108.86M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $115.40M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $97.76M | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | $102.49M | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $106.30M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $109.07M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $112.34M | Jun 13, 2024 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $82.63M | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | $84.99M | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | $132.13M | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | $122.87M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $123.31M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $109.42M | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | $110.18M | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $107.03M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $104.84M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $102.82M | Jun 13, 2024 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($21.62M) | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | ($14.65M) | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | ($24.10M) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | ($14.01M) | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | ($7.90M) | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | ($11.66M) | Jun 13, 2024 |
| FY2024 | Mar 31, 2022 | ($7.69M) | Sep 27, 2024 |
| FY2022 | Dec 31, 2021 | ($726.0K) | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $4.23M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $9.52M | Jun 13, 2024 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($977.00M) | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | ($969.81M) | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | ($977.20M) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | ($966.87M) | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | ($960.53M) | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | ($956.78M) | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | ($952.58M) | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | ($945.28M) | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | ($940.00M) | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | ($934.43M) | Jun 13, 2024 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | $12.84M | Jun 13, 2024 |
| FY2023 | Dec 31, 2022 | $16.62M | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | $23.78M | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | $16.91M | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | $22.56M | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | $31.27M | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | $38.27M | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | $49.22M | Jun 13, 2024 |
| FY2022 | Mar 31, 2021 | $49.53M | Jun 13, 2024 |
| FY2022 | Dec 31, 2020 | $31.97M | Jun 13, 2024 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $32.18M | Jun 27, 2025 |
| FY2024 | Mar 31, 2024 | $28.91M | Sep 27, 2024 |
| FY2022 | Mar 31, 2022 | $51.00M | Jun 13, 2024 |
| FY2021 | Mar 31, 2021 | $51.00M | Jun 14, 2021 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | (1) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | 0 | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | 0 | Jun 13, 2024 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jun 27, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jun 27, 2025 |
| FY2024 | Mar 31, 2023 | (1) | Sep 27, 2024 |
| FY2023 | Dec 31, 2022 | 0 | Jun 13, 2024 |
| FY2023 | Sep 30, 2022 | 0 | Jun 13, 2024 |
| FY2023 | Jun 30, 2022 | 0 | Jun 13, 2024 |
| FY2022 | Mar 31, 2022 | 0 | Jun 13, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Jun 13, 2024 |
| FY2022 | Sep 30, 2021 | 0 | Jun 13, 2024 |
| FY2022 | Jun 30, 2021 | 0 | Jun 13, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Mar 31, 2023 | 18.39M | Jun 13, 2024 |
| FY2023 | Mar 31, 2022 | 15.30M | Jun 13, 2024 |
| FY2022 | Mar 31, 2021 | 12.82M | Jun 13, 2024 |
| FY2021 | Mar 31, 2020 | 10.23M | Jun 14, 2021 |
| FY2020 | Mar 31, 2019 | 7.19M | Jun 29, 2020 |
| FY2019 | Mar 31, 2018 | 56.92M | Jun 11, 2019 |
| FY2018 | Mar 31, 2017 | 38.80M | Jun 7, 2018 |
| FY2017 | Mar 31, 2016 | 23.75M | Jun 13, 2017 |
| FY2016 | Mar 31, 2015 | 16.53M | Jun 9, 2016 |
| FY2015 | Mar 31, 2014 | 310.38M | Jun 15, 2015 |